Currently, there are 57.86M common shares owned by the public and among those 56.76M shares have been available to trade.
The company’s stock has a 5-day price change of 3.63% and 19.14% over the past three months. MMSI shares are trading 27.28% year to date (YTD), with the 12-month market performance up to 46.11% higher. It has a 12-month low price of $62.58 and touched a high of $96.85 over the same period. MMSI has an average intraday trading volume of 419.74K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 5.85%, 10.27%, and 22.07% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Merit Medical Systems, Inc. (NASDAQ: MMSI) shares accounts for 104.82% of the company’s 57.86M shares outstanding.
It has a market capitalization of $5.63B and a beta (3y monthly) value of 0.86. The stock’s trailing 12-month PE ratio is 48.19, while the earnings-per-share (ttm) stands at $2.01. The company has a PEG of 4.14 and a Quick Ratio of 4.64 with the debt-to-equity ratio at 0.68. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.63% over the week and 2.13% over the month.
Analysts forecast that Merit Medical Systems, Inc. (MMSI) will achieve an EPS of 0.8 for the current quarter, 0.84 for the next quarter and 3.69 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.79 while analysts give the company a high EPS estimate of 0.79. Comparatively, EPS for the current quarter was 0.75 a year ago. Earnings per share for the fiscal year are expected to increase by 10.07%, and 11.38% over the next financial year. EPS should shrink at an annualized rate of 11.63% over the next five years, compared to 15.74% over the past 5-year period.
Looking at the support for the MMSI, a number of firms have released research notes about the stock. Robert W. Baird stated their Outperform rating for the stock in a research note on June 28, 2024, with the firm’s price target at $96. CL King coverage for the Merit Medical Systems, Inc. (MMSI) stock in a research note released on April 11, 2024 offered a Buy rating with a price target of $88. BofA Securities was of a view on February 07, 2024 that the stock is Neutral, while Canaccord Genuity gave the stock Buy rating on December 21, 2023, issuing a price target of $100. Canaccord Genuity on their part issued Hold rating on December 20, 2022.
